Estrigenix Therapeutics co-founders Dr. Karyn Frick of UW-Milwaukee and Dr. Daniel Sem of Concordia University presented their research findings to an engaged audience at the UW-Milwaukee Innovation Accelerator on May...
Although Froedtert & the Medical College of Wisconsin’s partner on two planned micro hospitals closed its business, the health care system is proceeding with the facilities in Mequon and Oak...
Researchers are exploring ways to regrow damaged tissues using specialized blood cells that play a role in diseases such as fibrosis. These fibrocytes cluster around wounds once they start healing, changing...
Today, U.S. Rep. Ron Kind introduced the bipartisan Rural Access to Hospice Act, which will help ensure Wisconsin seniors and their families have access to hospice care in rural communities. Unfortunately many patients...
The Program for Advanced Cellular Therapy (PACT) at UW Health recently hired Andrea Pennati as its first associate director of research and development. In this role, Pennati will enable treatments developed...
A precision medicine company started by a Wisconsin entrepreneur has completed a $5 million funding round, with a goal of improving health outcomes for premature babies. Astarte Medical co-founder and Chief...
If the proposed merger between Marshfield Clinic Health System and Gundersen Health System goes through, the combined system could serve patients in more than 50 counties in Wisconsin, Minnesota and...
A new drug discovery and development company is taking root in Madison, and it will prevent more than a dozen skilled scientists here from losing their jobs. Nimble Therapeutics formed in April,...
In a Phase 2 clinical study of Cellectar's lead drug candidate on patients with blood plasma cell cancer, researchers recorded a 30 percent response rate in the first 10 patients...
Exact Sciences Corp. hasn’t finished building its second big laboratory building to process Cologuard tests for colorectal cancer but the Madison cancer diagnostics company already is planning for lab No....